Within the pharmaceutical, biotechnology and industries alike, a common challenge is the replication of results when moving from the laboratory scale to commercial scale.
Many lab scale instruments can differ significantly from the equipment required to produce large volumes of the same material, due to the required characteristics to meet the scale’s demands (e.g. size, durability, materials of construction), and so scalability becomes a frequent issue.
In the field of high-pressure homogenisation, this can be particularly challenging within applications such as:
- Cell Disruption
- Particle Size Reduction